Alutard Sq

Alutard SQ is a subcutaneous allergy immunotherapy treatment designed to reduce sensitivity to dust mites. It contains extracts of Dermatophagoides farinae and Dermatophagoides pteronyssinus, formulated with aluminium hydroxide.

Alutard SQ is used for the treatment of allergic conditions caused by dust mites, such as allergic rhinitis and asthma. This immunotherapy helps the body build tolerance to allergens, potentially reducing symptoms over time. It is administered subcutaneously and is intended for long-term use under medical supervision.

Common effects of Alutard SQ may include localized reactions at the injection site, such as redness, swelling, or itching. Systemic reactions, although rare, can occur and may include symptoms like sneezing, nasal congestion, or itchy eyes. Severe allergic reactions are possible but uncommon.

Alutard SQ should be administered by a healthcare professional in a setting equipped to manage severe allergic reactions. Patients should inform their doctor about any existing allergies or medical conditions before starting treatment. Regular monitoring is essential to ensure safety and effectiveness.

Alutard SQ may interact with certain medications, including beta-blockers and antihistamines. Alcohol consumption should be avoided as it may exacerbate side effects. Patients should consult their healthcare provider about all current medications before beginning immunotherapy.